Research published in ACS infections Diseases claimed to have developed a new type of vaccine for cholera which consists of ‘virus-like particles. The polysaccharides are the main ingredients of the immunity giver vaccine.
The research has shown that when administered to mice, the vaccine has generated a long-lasting antibody response against cholera bacteria.
The current vaccine for cholera comprises a weakened V. cholera bacteria and is taken orally. The antibody response by this vaccine is not very satisfactory as the immunity provided by it does not last for long.
But now that researcher has almost developed a new vaccine from ‘virus-like particles'. The expectations are high that this novel vaccine will deliver what its developers are claiming.
Cholera is a serious illness caused by the infection of the Vibrio cholera bacterium. It is transmitted through consuming food infected by V cholera. Roughly 2200 to 145000 deaths due to cholera are recorded every year.